Count | |
4 | |
1 | |
1 | |
Antiphospholipid Syndrome/*blood/*complications/physiopathology | 1 |
2 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
5 | |
Antiphospholipid Syndrome/complications/epidemiology/genetics | 1 |
4 | |
7 | |
5 | |
1 | |
2 | |
1 | |
1 | |
1 | |
2 | |
6 | |
1 | |
1 | |
1 | |
2 | |
1 | |
8 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
8 | |
22 | |
1 | |
2 | |
1 | |
1 | |
1 | |
2 | |
Antibodies, Antiphospholipid/*biosynthesis/blood/isolation & purification | 1 |
1 | |
1 | |
2 | |
4 | |
2 | |
3 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
10 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
3 | |
1 | |
1 | |
1 | |
4 | |
1 | |
1 | |
2 | |
1 | |
1 | |
8 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
8 | |
Acquired Immunodeficiency Syndrome/blood/*complications/pathology | 1 |